As we previously demonstrated that Akkermansia muciniphila, a gut microbe with beneficial effects during obesity, could exert its effects through modulation of intestinal bioactive lipids related to the ECS, we tested whether intestinal NAPE-PLD mediated these effects. The gene discussed is GPLD1; the disease is obesity due to melanocortin 4 receptor deficiency.